BTIG Maintains Buy on Praxis Precision Medicine, Price Target $826
BTIG maintained its Buy rating on Praxis Precision Medicine's stock and set a price target of $826.00, implying a 191.3% upside from its previous close.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.